Journal profile · Multiple
ADMET and DMPK
ISSN 1848-7718 · International Association of Physical Chemists (IAPC) · Croatia
ADMET and DMPK: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.1 (journal website); diamond open access (no APC); no APC; review about 4 weeks (community reports); acceptance rate 20% (journal website); 61 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
ADMET and DMPK is published by International Association of Physical Chemists (IAPC) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Chemistry and Chromatography, Computational Drug Discovery Methods and Electrochemical sensors and biosensors, together about 28.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ADMET and DMPK is an open-access journal devoted to the rapid dissemination of new and original scientific results in medicinal chemistry, natural product, biophysical chemistry, analytical science, advanced materials, pharmacology and pharmacy. Particular emphases of the Journal are placed on understanding of the interactions between therapeutic agents (either synthetic or naturally occurring) and biological systems, in the context of in vitro and/or in vivo systems, including absorption, distribution, metabolism, excretion, toxicology or pharmacokinetics. The therapeutic areas of interest of the Journal include, but are not limited to: oncology, neuroscience, infection, cardiovascular, respiratory and immunology. For manuscripts reporting novel synthetic compounds, the Journal requires that: (1) the characterization data (e.g. HRMS, NMR) of the compounds must be included, (2) the molecular target of the compounds described must be known, and (3) must be demonstrated experimentally. For studies involving natural products, if the molecular target is unknown, some data to provide insight into the mechanism of action is required. The Journal does not accept submission on the actions of biological extracts of unknown chemical composition and/or unknown concentration. Studies supported by molecular docking and/or in silico predictions may be accepted provided that novel insights in molecular design and target engagement are revealed and must be supported by experimental data. Studies dealing with novel physiological based pharmacokinetic modeling approaches that complied with the Journal’s Modelling and simulation ethics (https://pub.iapchem.org/ojs/index.php/admet/pbpk) are particularly welcome. The Journal encourages studies dealing with latest progresses in materials science and their novel applications in the field of pharmacology and/or pharmacy. ADMET and DMPK welcome translational pharmacological studies including preclinical and early clinical proof-of-concept case studies. However, the Journal does not publish first in man phase I, phase II, III or IV studies. Studies based solely on meta-analysis are not acceptable. ADMET and DMPK publishes the following types of contributions: Original research papersOriginal research papers describe original experimental work according to the standard scientific format: Title page, abstract, keywords, abbreviations, introduction, materials and methods, results, discussion, references, figures and legends. There is
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editorial board by country: 1 in mainland China (about 33%); most named Mainland China 1, Macau, China 1, Netherlands 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Chemistry and ChromatographyChemistry10.4%
- Computational Drug Discovery MethodsComputer Science9.5%
- Electrochemical sensors and biosensorsEngineering8.7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8%
- Crystallization and Solubility StudiesMaterials Science6.6%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.7%
- Drug Transport and Resistance MechanismsMedicine5.5%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5.1Publisher website ·
- CiteScore 2026-06
- 7.5LetPub ·
- CiteScore (publisher)
- 7.5Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1.27LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 143OpenAlex ·
- 2-year mean citedness
- 5.02OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 99.35%LetPub ·
Volume
- Articles per year
- 67LetPub ·
Articles by year OpenAlex count · 426 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 47 | 47 | 30 |
| 2025 | 61 | 61 | 436 |
| 2024 | 40 | 40 | 277 |
| 2023 | 45 | 45 | 500 |
| 2022 | 24 | 24 | 434 |
| 2021 | 16 | 16 | 263 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 4 weeksLetPub ·
- Acceptance rate (publisher)
- 20%Publisher website ·
- Submission to publication (journal-reported)
- about 4 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- Templates
- Word
- Suggested reviewers
- Required, 3
- Graphical abstract
- Required
- Cover letter
- Required
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright
Creative Commons CC-BY 4.0 license Model summary
Published by the International Association of Physical Chemists under the terms of the Creative Commons CC-BY 4.0 license.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- International Association of Physical Chemists (IAPC)
- Country or region
- Croatia
- Language
- English
- ISSN
- 1848-7718
- Latest issue on the website
- Volume 14 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about ADMET and DMPK
What CAS zone is ADMET and DMPK in?
In the 2025 upgraded edition of the CAS Journal Ranking, ADMET and DMPK is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ADMET and DMPK?
The journal's website gives an impact factor of 5.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 7.5, h-index 31.
How long does peer review take at ADMET and DMPK?
Authors report an average review time of about 4 weeks; the journal's website gives an acceptance rate of 20%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ADMET and DMPK?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation; Templates: Word; Suggested reviewers: Required, 3; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ADMET and DMPK based?
Of the 3 board members whose country the journal's board page names, 1 (about 33%) are in mainland China; the countries named most often are Mainland China (1), Macau, China (1) and Netherlands (1). Counted from the institutions listed on the board page; for reference only.
Which databases index ADMET and DMPK?
According to LetPub and DOAJ records, ADMET and DMPK is indexed in ESCI, Scopus and DOAJ.
Is ADMET and DMPK open access, and what is the APC?
ADMET and DMPK is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .